Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Horizons in Cancer Research. Volume 54

Horizons in Cancer Research. Volume 54

9781633213890
1,140.24 zł
1,026.21 zł Save 114.03 zł Tax included
Lowest price within 30 days before promotion: 1,026.21 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
This book presents original results on the leading edge of cancer research. Topics discussed include the risk factors, diagnosis and treatment options for glioblastoma; the biology of the interleukin-2 (il-2)-based immunotherapies in cancer and autoimmune disease; rna interference (rnai)/rna activation (rnaa) for cancer therapeutics; melanoma progression to metastatic disease; proteins, polysaccharide-peptide complexes and polysaccharides with antiproliferative and anticancer activities of mushrooms; low-molecular-weight compounds with anticancer activity of mushroom origin; lifestyle and cancer prevention; and the pathology and pathogenesis of Hodgkins lymphoma.
Product Details
Nova Science Publishers Inc
74632
9781633213890
9781633213890

Data sheet

Publication date
2014
Issue number
1
Cover
hard cover
Pages count
227
Dimensions (mm)
178.00 x 254.00
Weight (g)
556
  • PrefaceGlioblastoma:: Risk Factors, Diagnosis and Treatment Options(André Ballesteros-Tato, Troy D. Randall, Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA)The Biology of the Interleukin-2 (IL-2)-Based Immunotherapies in Cancer and Autoimmune Disease(André Ballesteros-Tato, Troy D. Randall, Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA)OFF or ON:: RNA Interference (RNAi) / RNA Activation (RNAa) for Cancer Therapeutics(Sorah Yoon, John J. Rossi, Department of Molecular and Cellular Biology, Beckman Research, Institute of City of Hope, Duarte, California, USA)Melanoma Progression to Metastatic Disease:: The Role of the PI3K/AKT and Wnt/β-Catenin Pathways(Jaskiran Sidhu, Geetha Venkateswaran, Sujata Persad, Department of Pediatrics Faculty of Medicine and Dentistry University of Alberta, Edmonton, Alberta, Canada)For Complete Table of Contents, please visit our website athttps:://www.novapublishers.com/catalog/product_info.php?cPath=23_29&products_id=50487
Comments (0)
Viewed products

  • Frequently purchased together

    No products available